Search

Author/Creator Leff, Richard

2. Phase 1 study of romidepsin plus erlotinib in advanced non-small cell lung cancer. Issue 3 (December 2015)

Authors:
Gerber, David E.; Boothman, David A.; Fattah, Farjana J.; Dong, Ying; Zhu, Hong; Skelton, Rachel A.; Priddy, Laurin L.; Vo, Peggy; Dowell, Jonathan E.; Sarode, Venetia; Leff, Richard; Meek, Claudia; Xie, Yang; Schiller, Joan H.
Journal:
Lung cancer
Issue:
Volume 90:Issue 3(2015:Dec.)
Page Start:
534
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Using a novel NQO1 bioactivatable drug, beta‐lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer. Issue 1 (27th March 2017)

Authors:
Beg, Muhammad Shaalan; Huang, Xiumei; Silvers, Molly A.; Gerber, David E.; Bolluyt, Joyce; Sarode, Venetia; Fattah, Farjana; Deberardinis, Ralph J.; Merritt, Matthew E.; Xie, Xian‐Jin; Leff, Richard; Laheru, Daniel; Boothman, David A.
Other Names:
Melstrom Laleh G. guestEditor.; Singh Gagandeep guestEditor.; Fong Yuman guestEditor.
Journal:
Journal of surgical oncology
Issue:
Volume 116:Issue 1(2017)
Page Start:
83
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗